A double-blind clinical trial comparing alcuronium with pancuronium

Area of Science:

• Anesthesiology
• Pharmacology

Background:

• Muscle relaxants are crucial in balanced anesthesia for facilitating endotracheal intubation and surgical procedures.
• Alcuronium and pancuronium are neuromuscular blocking agents with distinct pharmacological profiles.
• Understanding their comparative efficacy and safety in clinical settings is essential for anesthetic practice.

Purpose of the Study:

• To compare the efficacy and safety of alcuronium and pancuronium as muscle relaxants during combined balanced anesthesia.
• To evaluate their impact on endotracheal intubation, muscle relaxation, anesthesia maintenance, and postoperative recovery.
• To assess hemodynamic effects, specifically blood pressure variations, between the two agents.

Main Methods:

• A randomized, double-blind clinical trial involving 40 female patients undergoing combined balanced anesthesia.
• Patients received either alcuronium or pancuronium as the muscle relaxant.
• Data collected included endotracheal intubation success, degree of muscle relaxation, anesthesia maintenance, postoperative recovery, and blood pressure monitoring.

Main Results:

• Endotracheal intubation at 2 minutes was statistically significantly better with pancuronium (p < 0.001).
• No significant differences were observed between alcuronium and pancuronium regarding muscle relaxation, anesthesia maintenance, or postoperative recovery.
• Pancuronium group exhibited significantly higher systolic and diastolic blood pressure at various time points compared to the alcuronium group (p < 0.05 to p < 0.001).

Conclusions:

• Pancuronium provides superior conditions for endotracheal intubation compared to alcuronium.
• Alcuronium is a more suitable choice when the avoidance of hypertensive episodes is a priority.
• Pancuronium may be preferred in situations where hypotension is a concern, due to its hypertensive effect.